Figure 1From: Kinome profiling of myxoid liposarcoma reveals NF-kappaB-pathway kinase activity and Casein Kinase II inhibition as a potential treatment optionExon 11 of the FUS gene is fused to exon 2 of the DDIT3 gene. The corresponding chimeric protein retains the RNA binding domain of the FUS protein.Back to article page